MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41385-020-0334-2

Медицинская библиотека · Mucosal immunology · 2020

A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection.

Bernasconi Valentina, Norling Karin, Gribonika Inta, Ong Li Ching, Burazerovic Sabina, Parveen Nagma, Schön Karin, Stensson Anneli, Bally Marta, Larson Göran, Höök Fredrik, Lycke Nils

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

This is a proof-of-principle study demonstrating that the combination of a cholera toxin derived adjuvant, CTA1-DD, and lipid nanoparticles (LNP) can significantly improve the immunogenicity and protective capacity of an intranasal vaccine. We explored the self-adjuvanted universal influenza vaccine candidate, CTA1-3M2e-DD (FPM2e), linked to LNPs. We found that the combined vector greatly enhanced survival against a highly virulent PR8 strain of influenza virus as compared to when mice were immunized with FPM2e alone. The combined vaccine vector enhanced early endosomal processing and peptide presentation in dendritic cells and upregulated co-stimulation. The augmenting effect was CTA1-enzyme dependent. Whereas systemic anti-M2e antibody and CD4+ T-cell responses were comparable to those of the soluble protein, the local respiratory tract IgA and the specific Th1 and Th17 responses were strongly enhanced. Surprisingly, the lung tissue did not exhibit gross pathology upon recovery from infection and M2e-specific lung resident CD4+ T cells were threefold higher than in FPM2e-immunized mice. This study conveys optimism as to the protective ability of a combination vaccine based on LNPs and various forms of the CTA1-DD adjuvant platform, in general, and, more specifically, an important way forward to develop a universal vaccine against influenza.

Для цитирования: Bernasconi Valentina, Norling Karin, Gribonika Inta, Ong Li Ching, Burazerovic Sabina, Parveen Nagma, Schön Karin, Stensson Anneli, Bally Marta, Larson Göran, Höök Fredrik, Lycke Nils. A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection.. Mucosal immunology. 2020. DOI: 10.1038/s41385-020-0334-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.